A Study to Evaluate the Effect of the Potent CYP3A4 Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-906 in Healthy Participants
Completed
Millennium Pharmaceuticals, Inc.
Phase 1
The purpose of this study is to evaluate the effect of the potent cytochrome P-450 (CYP) 3A4
inhibitor (itraconazole) on the single-dose PK of oral TAK-906 maleate.
Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants
Completed
Takeda
Phase 1
The purpose of this study is to evaluate safety, tolerability, pharmacokinetics, and
pharmacodynamics of single and multiple oral doses of TAK-906 in Japanese healthy male
participants.
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
Completed
Millennium Pharmaceuticals, Inc.
Phase 2
The purpose of this study is to evaluate the safety, PK and PD of TAK-906 in participants
with Gastroparesis (GP).
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
Completed
Millennium Pharmaceuticals, Inc.
Phase 2
The purpose of this study is to assess the efficacy and safety of treatment with 2 dose
levels of TAK-906 in adult participants with gastroparesis compared with placebo during 12
weeks of treatment.
A Trial to Evaluate the Effect of the Proton Pump Inhibitor Esomeprazole on the Single-dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants
Completed
Millennium Pharmaceuticals, Inc.
Phase 1
The purpose of this study is to evaluate the effect of the proton pump inhibitor (PPI)
esomeprazole on the single-dose PK of orally administered TAK-906.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
